Youth Suicide and Self-Harm Intervention: Clinical and Biological Outcomes Study
SHIELD
Development and Biological Efficacy Validation of Youth Suicide and Self-Harm Intervention Program
1 other identifier
interventional
100
1 country
1
Brief Summary
The goal of this clinical trial is to develop and evaluate youth-focused intervention programs for suicide and self-harm that are tailored to the psychological, developmental, and cultural characteristics of Korean adolescents and young adults. The study examines whether two structured, mindfulness-based intervention programs-one for middle and high school students and one for young adults-reduce suicidal ideation, self-harm behaviors, depressive symptoms, and emotion-regulation difficulties. The study also aims to determine whether these clinical improvements are associated with biological changes, including alterations in resting-state functional brain activity (e.g., ALFF, ReHo, and functional connectivity) and social rhythm patterns. The main questions this study seeks to answer are:
- Does the youth suicide and self-harm intervention program reduce suicidal ideation and self-injurious thoughts/behaviors?
- Does the program improve mood, sleep, hopelessness, and emotion regulation?
- Are improvements in clinical outcomes accompanied by changes in biological markers of suicide risk?
- Researchers will compare the intervention program to usual care provided in hospitals, schools, and community mental health settings. Participants will:
- Participate in the structured suicide/self-harm intervention program or receive usual care.
- Complete standardized assessments of mood, sleep, emotion regulation and suicide/self-harm risk.
- Undergo biological assessments, including resting-state fMRI and rhythm-related measures, at baseline and follow-up.
- Be followed for up to 12 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2025
CompletedFirst Submitted
Initial submission to the registry
February 1, 2026
CompletedFirst Posted
Study publicly available on registry
February 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
May 8, 2026
May 1, 2026
1.4 years
February 1, 2026
May 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change from Baseline in Suicidality (DSI-SS Score)
The DSI-SS is a 4-item self-report questionnaire designed to assess the frequency and intensity of suicidal ideation and impulses. Scores range from 0 to 12, with higher scores indicating greater severity of suicidality; a score of 3 or higher is considered the clinical cut-off for high suicide risk.
Baseline and Week 8, Baseline and Week 12
Change from Baseline in Functional Assessment of Self-Mutilation (FASM) Frequency Score
The FASM assesses the methods and frequency of non-suicidal self-injury (NSSI), as well as the functions maintaining the behavior. It distinguishes between Internal Functions (e.g., emotion regulation) and Social Functions (e.g., influencing others). The instrument yields data on the total frequency of self-mutilative behaviors and separate scores for these functional domains.
Baseline and Week 8, Baseline and Week 12
Change from Baseline in Self-Harm Screening Inventory (SHSI) Total Score
The SHSI is a 10-item self-report measure used to screen for non-suicidal self-injury (NSSI) behaviors over the past year. It assesses 10 specific methods of self-harm (e.g., cutting, hitting, overdosing) performed without the intent to die. Each item is scored as 0 (No) or 1 (Yes). Total scores range from 0 to 10; a score of 1 or higher (indicating any experience of self-harm) is the cut-off for recommending a visit to a psychiatrist.
Baseline and Week 8, Baseline and Week 12
Change from Baseline in Circadian rhythm stability
Circadian rhythm stability refers to the consistency of 24-hour rest-activity patterns across days, as assessed using wrist-worn actigraphy. Inter-daily Stability (IS) quantifies the degree of similarity between daily activity profiles across consecutive days, with values ranging from 0 to 1. Higher IS values indicate greater stability and synchronization of the circadian rest-activity rhythm.
Through the end of the intervention period (approximately 12 weeks)
Researcher-Defined NSSI and Suicide Attempt Frequency
These researcher-defined items assess the frequency of Non-Suicidal Self-Injury (NSSI) and suicide attempts. NSSI frequency is measured across four timeframes (lifetime, past year, past month, past week) using a 7-point ordinal scale ranging from 'Once' to '50 times or more'. Suicide attempts are assessed by total lifetime frequency (4-point scale) and the recency of the most recent attempt. Higher scores on frequency items indicate a greater number of incidents.
Baseline and Week 8, Baseline and Week 12
Change from Baseline in Social Rhythm Stabilization
The Social Rhythm Stabilization Score assesses the regularity of daily routines (e.g., sleep, activities) through the completion of a daily social rhythm log. Variability is derived using 'Max-Min' for durations and 'Circular Time Distance' for clock times. Lower values indicate greater stability. Scores are categorized as: Very Regular (≤ 30), Regular (31-60), Mildly Variable (61-90), Variable (91-120), Irregular (121-180), and Very Irregular (\> 180).
Daily throughout the intervention period (8 weeks)
Secondary Outcomes (13)
Change from Baseline in Barratt Impulsiveness Scale (BIS-II) Total Score
Baseline and Week 8, Baseline and Week 12
Change from Baseline in Difficulties in Emotional Regulation Scale-Short Form (DERS-SF) Total Score
Baseline and Week 8, Baseline and Week 12
Change from Baseline in Distress Tolerance Scale (DTS) Total Score
Baseline and Week 8, Baseline and Week 12
Change from Baseline in Generalized Anxiety Disorder-7 (GAD-7) Total Score
Baseline and Week 8, Baseline and Week 12
Change from Baseline in Patient Health Questionnaire (PHQ-9) Total Score
Baseline and Week 8, Baseline and Week 12
- +8 more secondary outcomes
Study Arms (2)
Youth Suicide and Self-Harm Intervention Program
EXPERIMENTALA structured modular intervention program integrating mindfulness-based techniques, Dialectical Behavior Therapy (DBT) skills, and social rhythm stabilization strategies for adolescents and young adults at elevated risk for suicide and self-harm. The program includes tailored modules addressing: suicidal ideation and self-injurious thoughts/behaviors emotion regulation and distress tolerance (DBT-informed) mindfulness and attention regulation sleep and social rhythm stabilization crisis response and safety planning Modules are delivered by trained clinicians using a standardized manual, with components adjusted to the developmental needs of adolescents versus young adults. Participants complete psychological and biological assessments (e.g., resting-state fMRI) at baseline and follow-up.
General Mental Health Education Program
ACTIVE COMPARATORParticipants in the active comparator group will receive a general mental health education program of equal duration and session frequency as the intervention group. The education program covers topics such as: understanding stress and mood healthy coping strategies lifestyle factors related to mental well-being sleep hygiene healthy routines and social relationships This program does not include suicide- or self-harm-specific therapeutic components, nor modular DBT/mindfulness/rhythm stabilization strategies used in the intervention group. Participants complete the same baseline and follow-up psychological and biological assessments as the intervention group.
Interventions
A structured, module-based psychological intervention program consisting of 8 weekly sessions. The program is tailored into three customized tracks based on the participant's age and clinical needs: * Common Core Module (Cross-cutting): Social Rhythm Therapy (SRT) is applied to all participants starting from Session 2 to stabilize daily routines (sleep, meals, activities) and reduce emotional impulsivity. * Track 1: Youth Self-Harm Program (Ages 14-18): Focuses on functional understanding of non-suicidal self-injury, mindfulness-based emotion regulation, interpersonal skills, and behavioral therapy. * Track 2: Youth Suicide Program (Ages 14-18): Includes an intensive behavioral therapy session (Session 3) for crisis analysis, followed by mindfulness, interpersonal skills, and cognitive therapy modules to enhance resilience and prevent suicide attempts. * Track 3: Young Adult Program (Ages 19-30): Addresses both self-harm and suicide-related issues through personalized modules inc
Participants watch 8 educational videos over an 8-week period. The education is ideally conducted at the research site. Similar to the intervention group, participants are also required to use a wearable device during the study period.
Eligibility Criteria
You may qualify if:
- General Criteria
- Aged between 15 and 30 years
- Obtained informed consent from a parent or legal guardian for participants under 19 years of age
- For the Self-Harm Group
- At least one incident of non-suicidal self-injury (NSSI) within the last 6 months
- Self-Harm Screening Inventory (SHSI) score of at least 1 (at least one "Yes" response)
- For the Suicide Attempt Group
- Suicide attempt within the last 6 months
- Depressive Symptom Inventory-Suicidality Subscale (DSI-SS) score of 3 or higher
You may not qualify if:
- Psychiatric and Developmental Conditions
- History of developmental disorders, including intellectual disability or autism spectrum disorder
- Diagnosis of schizophrenia or bipolar disorder
- Currently in an acute psychotic state
- Medical and Physical Conditions
- Presence of severe physical illness that interferes with daily life
- Presence of metallic substances in the body (e.g., cardiac pacemakers, artificial heart valves) that are incompatible with fMRI
- Diagnosis of claustrophobia
- Current Treatment and Intervention
- Currently receiving regular and active cognitive behavioral therapy (CBT)
- Initiation of pharmacological treatment within the last 2 months
- Communication and Consent
- Inability to communicate fluently in Korean
- Failure to obtain informed consent from a parent or legal guardian for participants under 19 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ajou University School of Medicinelead
- Korea Health Industry Development Institutecollaborator
- Sungshin Women's Universitycollaborator
Study Sites (1)
Ajou University Medical Center
Suwon, Gyeonggi-do, 16499, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors will be blinded to participant assignment to minimize assessment bias.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 1, 2026
First Posted
February 9, 2026
Study Start
July 30, 2025
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
May 8, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared outside the primary research group. This study involves sensitive data collected from minors and young adults pertaining to suicidal ideation, suicide attempts, and non-suicidal self-injury. Given the highly sensitive and potentially identifiable nature of this information, sharing de-identified IPD with external researchers is not planned, in order to protect participant confidentiality and ensure compliance with Korean data protection regulations (Personal Information Protection Act) and institutional ethics requirements.